BNTX - BioNTech SE
100.76
-6.720 -6.669%
Share volume: 1,497,397
Last Updated: 03-03-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.31%
PREVIOUS CLOSE
CHG
CHG%
$107.48
-6.72
-0.06%
View ratios
| Fiscal Date | 03-31-2024 | |
|---|---|---|
| Fiscal Quarter | Q1 2024 | |
| Report Date | 05-06-2024 | |
| Total revenue | 202.610 M | |
| Cost of revenue | 63.829 M | |
| Gross profit | 138.781 M | |
| Operating expenses | 691.315 M | |
| Selling general and admin | 143.209 M | |
| Research and development | 548.105 M | |
| Total expenses | 755.143 M | |
| Operating income | -552.533 M | |
| Ebit | -552.533 M | |
| Pretax income | -358.347 M | |
| Income tax | -18.036 M | |
| Net income basic | -340.311 M | |
| Net income | -340.311 M | |